Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07286578 · ClinicalTrials.gov registry record · NA
A Prospective, Multicenter, Randomized Controlled Trial to Investigate the Value of Coronary CT Angiography in the Understanding and Management of Coronary Calcium (The Optimal Trial)
A NA study of Cardiovascular Diseases and Coronary Artery Disease, sponsored by Fundación EPIC.
- Recruiting
- Registry status
- NA
- Development phase
- 700
- Enrollment target
- 13
- Study locations
NCT07286578 is a NA study of Cardiovascular Diseases and Coronary Artery Disease that is actively recruiting participants, run by Fundación EPIC. The registered enrollment target is 700 participants, below the 26,972-participant average among 300 other Cardiovascular Diseases trials with a reported enrollment target (97% lower). The trial reports 13 study locations across 5 states.
The verdict
NCT07286578, a NA study of Cardiovascular Diseases and Coronary Artery Disease, is actively recruiting participants, sponsored by Fundación EPIC.
- RECRUITING
- Registry status
- NA
- Development phase
- 700 participants
- Enrollment target
- 13
- Study locations
Study Summary
The OPTIMAL randomized clinical trial has been designed to compare two imaging strategies and to test the hypothesis that a calcium modification strategy informed by coronary CT angiography (CCTA) will improve procedural efficiency and effectiveness compared with the current standard of care (IVUS-guided PCI) while achieving similar clinical outcomes in patients with hemodynamically significant calcified coronary artery disease.
Conditions Studied
Interventions
- DEVICE CT(Computed Tomography) guided Percutaneous Coronary Intervention
- DEVICE IVUS (Intravascular Ultrasound) guided Percutaneous Coronary Intervention
Study Locations (13)
Other
- Hospital Universitari Vall Hebron - Barcelona
- Hospital Universitario de Leon - León
- Hospital Universitario La Paz - Madrid
- University Hospitals of Leicester NHS Trust - Leicester
- St Bartholomew's Hospital (Barts Health NHS Trust) - London
- St George's University Hospitals NHS Foundations Trust - London
- Newcastle Hospitals NHS Foundations Trust - Newcastle
- John Radcliffe Hospital, Oxford - Oxford
New York
- Columbia University Irving Medical Center/NewYork-Presbyterian Hospital - New York
- Weill Medical College of Cornell University - New York
Massachusetts
- Bringham and Women's Hospital - Boston
Minnesota
- Minneapolis Heart Institute - Minneapolis
New Jersey
- HACKENSACK MERIDIAN HEALTH, Inc - Jersey City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 700 participants |
| Start Date | 2025-12-22 |
| Est. Completion | 2030-01-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07286578
The ClinicalTrials.gov registry entry for NCT07286578 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 700 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 26,972-participant average among 300 other Cardiovascular Diseases trials with a reported enrollment target (97% lower). The listed sponsor is Fundación EPIC, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 7 conditions, with Cardiovascular Diseases appearing as the primary indexed condition, and to 2 interventions - of which CT(Computed Tomography) guided Percutaneous Coronary Intervention is the first listed.
NCT07286578 reports 13 study locations spanning 5 distinct geographic areas - top geographies include Other, New York, Massachusetts.
Frequently Asked Questions
What is clinical trial NCT07286578 about?
NCT07286578 is a clinical study titled "A Prospective, Multicenter, Randomized Controlled Trial to Investigate the Value of Coronary CT Angiography in the Understanding and Management of Coronary Calcium (The Optimal Trial)". The OPTIMAL randomized clinical trial has been designed to compare two imaging strategies and to test the hypothesis that a calcium modification strategy informed by coronary CT angiography (CCTA) will improve procedural efficiency and effectiveness compared with the current standard of care (IVUS-g...
What is the current status of trial NCT07286578?
This trial is currently recruiting. It is a NA study. The enrollment target is 700 participants. The study started on 2025-12-22. Estimated completion is 2030-01-01.
What conditions does trial NCT07286578 study?
This clinical trial studies the following conditions: Cardiovascular Diseases, Coronary Artery Disease, Heart Diseases, Vascular Diseases, Myocardial Ischemia.
What interventions are being tested in trial NCT07286578?
The interventions under investigation include: CT(Computed Tomography) guided Percutaneous Coronary Intervention (DEVICE), IVUS (Intravascular Ultrasound) guided Percutaneous Coronary Intervention (DEVICE).
Who is sponsoring clinical trial NCT07286578?
This trial is sponsored by Fundación EPIC, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07286578 being conducted?
This trial has 13 study locations across Massachusetts, Minnesota, New Jersey, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cardiovascular Diseases
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
The Influence of Chardonnay Marc Intake on Gut and Cardiometabolic Health
RECRUITING · NA
-
Identifying Strategies to Reduce Cardiovascular Risk Among Mothers of Young Children
RECRUITING · NA
-
Insomnia Treatment and Cardiometabolic Health in Older Adults With Posttraumatic Stress Disorder
RECRUITING · NA
-
Deep Brain Stimulation Motor Ventral Thalamus (VOP/VIM) for Restoration of Speech and Upper-limb Function in People With Subcortical Stroke
RECRUITING · NA
-
Effects of Whole vs. Nonfat Milk Consumption on Body Composition in Children
RECRUITING · NA
-
MagicTouch for Treatment of In-Stent Restenosis in Coronary Artery Lesions
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.